This content is for informational purposes only and is not a substitute for professional advice.
Creatine monohydrate is the default because it has the deepest evidence base; creatine HCL is mainly a tolerability or preference experiment inside the same dose windows logic.
Methodology
The comparison scores each form on human evidence, dose clarity, cost, side-effect management, and ability to interpret a home trial.
| Criterion | Monohydrate | HCL |
|---|---|---|
| Evidence base | Strongest | Much thinner |
| Typical trial dose | 3-5 g daily | Label-directed, often lower gram dose |
| Cost | Usually lower | Usually higher |
| Best reason to choose | First creatine trial | GI preference after monohydrate issue |
| Claim to distrust | Instant muscle gain | Superior results from tiny doses |
Recommendation
Start with creatine monohydrate unless there is a clear reason not to. It is the form used in most sports nutrition evidence and position stands. HCL may be worth testing if monohydrate causes GI discomfort, but the decision should be framed as tolerability, not proven superiority.
Testing protocol
| Phase | Rule |
|---|---|
| Baseline | 14 days of training and body-weight logs |
| Monohydrate test | 3-5 g daily for 42 days |
| Switch test | HCL only after a washout or stable transition note |
| Endpoint | Training volume, repeat efforts, GI tolerance |
| Lab caution | Discuss kidney labs with a clinician if monitored |
Sources
This article is educational and does not replace medical advice.
Kreider RB, et al. ISSN position stand: creatine. https://pubmed.ncbi.nlm.nih.gov/28615996/
↩Avgerinos KI, et al. Creatine and cognition review. https://pubmed.ncbi.nlm.nih.gov/29704637/
↩NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/
↩